The FDA Just Recalled Nearly 10 Million Pounds of Ready-to-Eat Meat and Poultry Nationwide
According to the FDA announcement, the recall includes approximately 9,986,245 pounds of ready-to-eat meat and poultry ...
Bakery that makes Sara Lee and Entenmann’s pushes back on FDA sesame warning
Bimbo Bakeries USA is pushing back on an FDA warning to stop using labels that say its products contain sesame when they ...
Why Ozempic, Zepbound, and other weight-loss drug dupes carry risks
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...
Knockoff weight loss drug sellers are fighting back against Eli Lilly and the FDA
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...
AI Simulations Help Drug Trials
AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...
Cash shortages and complex rules impede Native American health-care access
Correction: In a Sept. 20 Q&A with Health Brief, Rep. Brad Wenstrup (R-Ohio) said Rep. John James (Mich.) was among the ...
Army says to avoid poppy seeds and targets delta-8 in substance abuse regs
Updates to the Army’s substance abuse regulations tell soldiers not to eat poppy seeds and bans delta-8, a cannabis ...
Business Wire12d
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treat…
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in ...
NBC New York14d
FDA issues recall notices over 2 brands of pet food due to salmonella and listeria risk
Amid an ongoing pet food recall, the U.S. Food and Drug Administration (FDA) is urging pet owners not to give their ...
STAT1d
Q&A: How the FDA is approaching AI in clinical trials and drug development
The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.